Albert David Limited has appointed Amit Mahla as Whole-time Director and Chief Executive Officer (CEO) for a period of five years effective June 19, 2026. The Board of Directors approved the appointment based on the recommendations of the Nomination and Remuneration Committee and the Audit Committee. This leadership change is subject to the approval of shareholders at the company's upcoming 87th Annual General Meeting (AGM). The decision aims to strengthen the company's executive governance structure and leverage Mahla's extensive experience in the pharmaceutical sector.

Mahla, who has served as CEO since May 12, 2026, was inducted as an Additional Director on the Board with immediate effect from June 19, 2026. His tenure as Whole-time Director & CEO is scheduled to run until June 18, 2031, contingent upon ratification by the shareholders. The Board has fixed his remuneration for the period from June 19, 2026, to March 31, 2027. Consequently, the notice for the 87th AGM has been revised to include resolutions seeking shareholder approval for the regularisation, appointment, and remuneration fixation for Mahla. The dates for the AGM, record date for dividend payment, and book closure remain unchanged.

Profile of the Appointee

Amit Mahla, aged 52, brings over 28 years of experience to the role. He holds a degree in Science, a postgraduate degree in English Literature, and an Executive MBA from SIES, Mumbai. His career spans leadership roles at major pharmaceutical firms including Cipla, Emcure, Glenmark, Alembic, Sun Pharma, and JB Pharma. Prior to joining Albert David, he was associated with JB Pharma. He is recognized for transforming underperforming businesses into high growth engines and has led the integration of Sanzyme into JB Pharma.

Key Appointment Details

The company confirmed that Mahla is not related to any director or key managerial personnel of the company and is not debarred from holding the directorship by the Securities and Exchange Board of India (SEBI) or any other authority.

Albert David Limited has announced the resignation of Mr. Chandra Bhushan Thakur from the position of Head-Operations at its Ghaziabad Plant. The resignation is effective from the close of business hours on May 29, 2026. The company disclosed that the departure was due to personal reasons, marking a change in the plant's operational leadership.

The intimation was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was submitted to BSE Limited and the National Stock Exchange of India Limited on May 30, 2026, by Lalit Lohia, the Company Secretary & Compliance Officer. The company acknowledged Mr. Thakur's contributions during his tenure.

Details of Resignation

The following table outlines the specific details regarding the change in senior managerial personnel as provided in the regulatory filing:

The resignation was communicated internally via email from the HR Department, confirming the discontinuation of Mr. Thakur's retainership services. Albert David Limited has requested the exchanges to place the information on record.